Home
>
National Drug Code (NDC)
>
Cyclobenzaprine Hydrochloride
Cyclobenzaprine Hydrochloride - 0115-1437-13 - (CYCLOBENZAPRINE HYDROCHLORIDE)
Drug Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 0115-1437 |
| Proprietary Name: | Cyclobenzaprine Hydrochloride |
| Non Proprietary Name: | CYCLOBENZAPRINE HYDROCHLORIDE |
| Active Ingredient(s): | 30 mg/1 & nbsp; CYCLOBENZAPRINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cyclobenzaprine Hydrochloride
| Product NDC: | 0115-1437 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021777 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20110701 |
Package Information of Cyclobenzaprine Hydrochloride
| Package NDC: | 0115-1437-13 |
| Package Description: | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13) |
NDC Information of Cyclobenzaprine Hydrochloride
| NDC Code | 0115-1437-13 |
| Proprietary Name | Cyclobenzaprine Hydrochloride |
| Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13) |
| Product NDC | 0115-1437 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110701 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
